p53 and cancer therapy: a double-edged sword

被引:30
作者
McGill, G
Fisher, DE
机构
[1] Dana Farber Canc Inst, Div Pediat Hematol Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Grad Program Biol & Biomed Sci, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1172/JCI7861
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:223 / 225
页数:3
相关论文
共 21 条
[1]  
Ahnen DJ, 1998, CANCER RES, V58, P1149
[2]  
Benhattar J, 1996, INT J CANCER, V69, P190, DOI 10.1002/(SICI)1097-0215(19960621)69:3<190::AID-IJC7>3.0.CO
[3]  
2-V
[4]  
Brown JM, 1999, CANCER RES, V59, P1391
[5]   Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[6]   P53-DEPENDENT APOPTOSIS IN THE ABSENCE OF TRANSCRIPTIONAL ACTIVATION OF P53-TARGET GENES [J].
CAELLES, C ;
HELMBERG, A ;
KARIN, M .
NATURE, 1994, 370 (6486) :220-223
[7]   Oncogene-dependent regulation of caspase activation by p53 protein in a cell-free system [J].
Ding, HF ;
McGill, G ;
Rowan, S ;
Schmaltz, C ;
Shimamura, A ;
Fisher, DE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) :28378-28383
[8]   INDUCTION OF APOPTOSIS IN FIBROBLASTS BY C-MYC PROTEIN [J].
EVAN, GI ;
WYLLIE, AH ;
GILBERT, CS ;
LITTLEWOOD, TD ;
LAND, H ;
BROOKS, M ;
WATERS, CM ;
PENN, LZ ;
HANCOCK, DC .
CELL, 1992, 69 (01) :119-128
[9]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[10]   APOPTOSIS IN CANCER-THERAPY - CROSSING THE THRESHOLD [J].
FISHER, DE .
CELL, 1994, 78 (04) :539-542